The Aim of this proposal is to determine if replication competent but attenuated strains of vaccinia virus can be used as a vector to induce a broad mucosal immune response to inserted genes that encode HIV epitopes. A gene coding for a V3 loop multi-epitope polypeptide will be inserted into a non-essential locus of replication competent, attenuated strains of vaccinia virus. These viruses will be analyzed for expression of the HIV multi-epitope polypeptide and for replication in nasal tissue of infected animals. Animals will be immunized intra-nasally either with virus alone or as part of a prime-boost regime. Systemic, nasal and vaginal immune responses to the HIV multi-epitope polypeptide will be analyzed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI052787-02
Application #
6653090
Study Section
Special Emphasis Panel (ZRG1-VACC (03))
Program Officer
Butler, Robert C
Project Start
2002-09-01
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2003
Total Cost
$224,250
Indirect Cost
Name
Arizona State University-Tempe Campus
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
943360412
City
Tempe
State
AZ
Country
United States
Zip Code
85287